DOUTOR NICHIRES Holdings Co Ltd
3087・Prime Market・Retail Trade
Business
Doutor Nichiryo Holdings Co., Ltd. is a joint holding company established in 2007 through a joint share transfer by Doutor Coffee Co., Ltd. and Nippon Restaurant System Co., Ltd. It oversees 23 subsidiaries and 2 affiliated companies, covering a broad range of operations from coffee roasting/processing and sales to the direct and franchise operation of multi-format restaurant chains. Its core brands include "Doutor Coffee Shop," "Hoshino Coffee," and "Yomenya Goemon." In addition to its domestic store network, it also operates directly-owned stores overseas in Singapore, Taiwan, and Korea. The company also engages in a wholesale business supplying coffee products to convenience stores and mass retailers, with consolidated net sales for FY2026 (ending March 2026) reaching a record high of ¥159,147 million. Its main customers span a wide range of domestic and international food and beverage consumers, including business people, families, and seniors.
Business Model
Revenue is structured on three pillars: (1) the Doutor Coffee Group's directly operated store sales, coffee bean wholesale to franchise stores, and royalty income (external customer sales of ¥96,344 million), (2) the Nippon Restaurant System Group's directly operated and franchise operation of multi-format restaurants (external customer sales of ¥56,260 million), and (3) the wholesale business of chilled beverages, drip coffee, and other products for convenience stores and supermarkets. A vertically integrated supply chain with in-house roasting plants and cost control through shared use of common ingredients underpin profit margins. The company maintains a debt-free management policy, funding capital expenditures and working capital essentially from its own funds.
Company Strengths
After posting an operating loss of ¥1,783 million in FY2022 (ended February 2022), the company turned profitable in FY2023 (ended February 2023). In FY2026 (ending February 2026), net sales reached ¥159,147 million (up 6.9% year on year) and operating profit reached ¥10,150 million, both record highs. Over the four-year period, operating profit expanded sharply from a loss to ¥10,150 million, demonstrating strong earnings recovery capability.
At the end of FY2025 (ended February 2025), the equity ratio stood at 77.5%, and the market-value-based equity ratio was 78.0% (rising to 92.2% in FY2026, ending February 2026). Interest-bearing debt is extremely low, with a cash flow to interest-bearing debt ratio of 0.1 years. The company holds ¥38,990 million in cash and cash equivalents, maintaining financial soundness that allows it to fund capital expenditure and shareholder returns from its own resources.
The group holds both a coffee chain centered on "Doutor Coffee Shop" and multi-format restaurants such as "Hoshino Coffee" (269 domestic stores) and "Yomenya Goemon" within the same group. Cost management through shared use of common ingredients and logistics, combined with store portfolio optimization via format conversions (22 stores in FY2025, ended February 2025), serve as differentiating factors against competitors.
ENVALITH's Perspective
Performance Trend
Revenue grew 45% over five fiscal years, from ¥109,363 million in FY2022 to ¥159,147 million in FY2026. Cumulative revenue for Q1 of FY2027 (ending February 2027) reached ¥42,528 million (up 8.2% year on year), maintaining the revenue growth trend. Operating profit recovered sharply from a loss of ¥1,783 million in FY2022 to reach ¥10,150 million in FY2026, and accelerated further with Q1 FY2027 alone recording ¥3,770 million (up 35.2% year on year). External factors such as wage increases and the recovery in foot traffic driven by inbound demand have provided tailwinds, while persistently high commodity prices are pushing up costs, with cost of sales rising to ¥17,436 million (up 9.4% year on year), outpacing revenue growth. The full-year operating profit forecast of ¥11,043 million (up 8.8% year on year) remains unchanged.
Growth Strategy
Aiming to become an excellent leading company through premium-priced products, wholesale expansion, and carefully selected new store openings
The company continues to introduce value-added products such as the renewed grand menu (including Yoshoku-ya Gorgonzola, etc.) and seasonal limited items and frozen drinks such as "Mil Che," aiming to expand sales through higher average spend per customer. Results are already visible in the numbers, with existing-store sales in Q1 of FY2027 (ending February 2027) up year on year at Doutor (104.2%) and Nichires (102.4%).
The company is significantly expanding sales of drip and instant coffee through mail order, mass retailers, and drugstores, increasing both the number of business partners and the number of products sold. It is also strengthening development of new PB and NB chilled beverage products for convenience stores. Wholesale sales in Q1 of FY2027 (ending February 2027) reached ¥15,172 million (up 16.8% year on year), continuing to expand rapidly.
The group carefully selects locations and opened 9 new stores in Q1 (5 directly operated, 4 franchised) across the group as a whole. It is also pursuing a new location strategy of opening stores inside parks, aiming to expand beyond existing trade areas. The Nihon Restaurant System group opened 3 stores, including Yoshoku-ya Gorgonzola locations.
The company continues promotional measures centered on cashless campaigns, driving both new customer acquisition and repeat customer retention. These measures have also contributed to improved customer traffic during morning hours, continuing to support the overall recovery in sales.
Last updated: July 17, 2026

